Drugs (Pharmaceuticals) – Page 68

Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuits Nationwide

The money would help pay for addiction treatment and drug education programs in communities across the United States.

By Jan Hoffman

Black People Buprenorphine (Drug) Drug Abuse and Traffic Drugs (Pharmaceuticals) Hispanic-Americans Minorities Opioids and Opiates Race and Ethnicity Research United States Whites

Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Finds

The analysis of 15 years of prescription data showed that the racial disparities are widening.

By Emily Baumgaertner

CVS Caremark Corporation Drugs (Pharmaceuticals) Drugstores Native Americans Opioids and Opiates Shopping and Retail States (US) Suits and Litigation (Civil) Walgreen Co

CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases

The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.

By Jan Hoffman

Depression (Mental) Drugs (Pharmaceuticals) Intellectual Property Inventions and Patents Mental Health and Disorders Psychedelic and Hallucinogenic Drugs Research

With Promise of Legalization, Psychedelic Companies Joust Over Future Profits

Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.

By Andrew Jacobs